Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 [Phase 1, Phase 2]
Phase 1a/Phase 2 study evaluating safety, preliminary efficacy, PK and PD of ST-067 in various cancers; currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial update shows BEBT-209 in combination with chemotherapy for advanced triple-negative breast cancer is currently recr…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Studying the Senescent T Cell Features and Its Relationship with the Chemotherapy Efficacy in Young TNBC
A clinical trial is studying senescent T cell features and their relationship to chemotherapy efficacy in young patients with triple-negativ…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial assessing TIL Gean Therapy in combination with immunotherapy for advanced or metastatic refractory breast cancer is curren…
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC [Phase 3]
This clinical trial update describes an ongoing Phase 3 study evaluating PARP inhibitor or capecitabine in combination with PD-1 inhibitors …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers [Phase 1]
This document reports a Phase 1 clinical trial of NI-1801 for mesothelin-expressing solid cancers, with recruiting status and multiple indic…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies
A clinical trial exploring cellular immune responses in triple-negative breast cancer using high-throughput immunogenetic studies is current…
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer [Phase 2]
A Phase 2 clinical trial is investigating simvastatin's effect on the epithelial-mesenchymal transition in triple-negative breast cancer. Re…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC [Phase 2]
A single-arm, prospective Phase II trial assessing Utidelone plus capecitabine for active brain metastases in triple-negative metastatic bre…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer [Phase 1, Phase 2]
Apatinib combined with Nab-paclitaxel (albumin-bound paclitaxel) is being studied in Phase 1/2 for advanced triple-negative breast cancer an…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial [Phase 2]
A Phase 2 clinical trial update for TONIC-3 evaluating novel immunotherapy strategies in advanced/metastatic triple-negative breast cancer; …
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Asian Multicenter Prospective Study of ctDNA Sequencing
Clinical trial update on an Asian multicenter prospective study evaluating circulating tumor DNA sequencing across multiple cancers, sponsor…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
The clinical trial assessing precision performance status in breast cancer patients receiving neoadjuvant chemotherapy has been terminated.
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: CTS2190 Phase I /II Clinical Study in Patients [Phase 1, Phase 2]
CTS2190 is a Phase 1/2 clinical study by CytosinLab Therapeutics evaluating CTS2190 in solid tumors, including pancreatic cancer, non-small …
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer
This clinical trial update reports on PD-L1 expression in HER2-positive breast cancer and triple-negative breast cancer. The study is active…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial is evaluating LM-108 in combination with a PD-1–based therapy for patients with recurrent or metastatic triple-nega…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study [Phase 2]
Open-phase 2 multicenter trial evaluating Milaberon in advanced solid tumors across multiple indications, currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating safety, tolerability, pharmacokinetics, and anti-tumor activity of novel therapeutics in patients with early re…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: A Phase II Study of Triple-negative Breast Cancer Brain Metastases. [Phase 2]
A Phase II clinical trial evaluating treatment for brain metastases in patients with triple-negative breast cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment [NA]
This clinical trial update describes an exercise intervention for women with triple-negative breast cancer undergoing oncologic treatment; t…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial is evaluating dasatinib in combination with quercetin to overcome chemotherapy resistance in triple-negative breast…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva) [Phase 2]
This is a Phase 2 clinical trial evaluating short-term pre-operative durvalumab (MEDI-4736) in patients with early-stage small triple-negati…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer [Phase 4]
Phase 4 clinical trial update on Huaier Granule as adjuvant treatment for high-risk early-stage triple-negative breast cancer; recruitment i…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer [EARLY_Phase 1]
This early-phase clinical trial evaluates an EGFR/B7H3-targeted CAR-T cell therapy for advanced lung cancer and advanced triple-negative bre…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer [Phase 1]
Ongoing Phase 1 study evaluating pembrolizumab (MK-3475) and its effects on the breast tumor microenvironment in triple-negative breast canc…